Europe Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)
The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028. It is estimated to record a CAGR of 9.3% from 2021 to 2028.
Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches Fuels Europe Sepsis Diagnostics Market Growth
Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfil this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. In September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model. The model shows that the use of the company's HostDxTM Sepsis test is cost-effective as compared to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in emergency departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. Thus, the rising demand for rapid diagnostics tests led to product launches, which is expected to drive the Europe sepsis diagnostics market during the forecast period.
Europe Sepsis Diagnostics Market Overview
The Europe sepsis diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Germany holds a significant market share in the Europe sepsis diagnostics market and is estimated to register a robust growth rate over the forecast period. Germany and the UK are expected to contribute majorly to the growth of the market in Europe. The Europe sepsis diagnostics market is expected to witness a significant growth during the forecast period due to factors such as the need for early diagnosis of sepsis, the high mortality rate of the medical condition, and its increasing prevalence.
Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Europe Sepsis Diagnostics Market Segmentation
The Europe sepsis diagnostics market is segmented the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the Europe sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the Europe sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the Europe sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the Europe sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the Europe sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the Europe sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2021.
Abbott; Axis-Shield Diagnostics Ltd; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. Are among the leading companies operating in the Europe sepsis diagnostics market.
Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches Fuels Europe Sepsis Diagnostics Market Growth
Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfil this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. In September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model. The model shows that the use of the company's HostDxTM Sepsis test is cost-effective as compared to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in emergency departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. Thus, the rising demand for rapid diagnostics tests led to product launches, which is expected to drive the Europe sepsis diagnostics market during the forecast period.
Europe Sepsis Diagnostics Market Overview
The Europe sepsis diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Germany holds a significant market share in the Europe sepsis diagnostics market and is estimated to register a robust growth rate over the forecast period. Germany and the UK are expected to contribute majorly to the growth of the market in Europe. The Europe sepsis diagnostics market is expected to witness a significant growth during the forecast period due to factors such as the need for early diagnosis of sepsis, the high mortality rate of the medical condition, and its increasing prevalence.
Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Europe Sepsis Diagnostics Market Segmentation
The Europe sepsis diagnostics market is segmented the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the Europe sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the Europe sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the Europe sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the Europe sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the Europe sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the Europe sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2021.
Abbott; Axis-Shield Diagnostics Ltd; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. Are among the leading companies operating in the Europe sepsis diagnostics market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Sepsis Diagnostics Market – By Product
1.3.2 Europe Sepsis Diagnostics Market – By Technology
1.3.3 Europe Sepsis Diagnostics Market – By Method
1.3.4 Europe Sepsis Diagnostics Market – By Test Type
1.3.5 Europe Sepsis Diagnostics Market – By Pathogen
1.3.6 Europe Sepsis Diagnostics Market – By End User
1.3.7 Europe Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. EUROPE SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Absence of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Growing Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– EUROPE ANALYSIS
6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis
7. EUROPE SEPSIS DIAGNOSTICS MARKET – BY PRODUCT
7.1 Overview
7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. EUROPE SEPSIS DIAGNOSTICS MARKET – BY TECHNOLOGY
8.1 Overview
8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. EUROPE SEPSIS DIAGNOSTICS MARKET – BY METHOD
9.1 Overview
9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. EUROPE SEPSIS DIAGNOSTICS MARKET – BY TEST TYPE
10.1 Overview
10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. EUROPE SEPSIS DIAGNOSTICS MARKET – BY PATHOGEN
11.1 Overview
11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. EUROPE SEPSIS DIAGNOSTICS MARKET – BY END USER
12.1 Overview
12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. EUROPE SEPSIS DIAGNOSTICS MARKET – BY COUNTRY ANALYSIS
13.1 Europe: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.5 France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.8 France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.1 Overview
13.1.2.5.2 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.1 Overview
13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
14. SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Axis-Shield Diagnostics Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Sepsis Diagnostics Market – By Product
1.3.2 Europe Sepsis Diagnostics Market – By Technology
1.3.3 Europe Sepsis Diagnostics Market – By Method
1.3.4 Europe Sepsis Diagnostics Market – By Test Type
1.3.5 Europe Sepsis Diagnostics Market – By Pathogen
1.3.6 Europe Sepsis Diagnostics Market – By End User
1.3.7 Europe Sepsis Diagnostics Market – By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE SEPSIS DIAGNOSTICS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion
5. EUROPE SEPSIS DIAGNOSTICS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Absence of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Growing Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. SEPSIS DIAGNOSTICS MARKET– EUROPE ANALYSIS
6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis
7. EUROPE SEPSIS DIAGNOSTICS MARKET – BY PRODUCT
7.1 Overview
7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. EUROPE SEPSIS DIAGNOSTICS MARKET – BY TECHNOLOGY
8.1 Overview
8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. EUROPE SEPSIS DIAGNOSTICS MARKET – BY METHOD
9.1 Overview
9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. EUROPE SEPSIS DIAGNOSTICS MARKET – BY TEST TYPE
10.1 Overview
10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. EUROPE SEPSIS DIAGNOSTICS MARKET – BY PATHOGEN
11.1 Overview
11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. EUROPE SEPSIS DIAGNOSTICS MARKET – BY END USER
12.1 Overview
12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. EUROPE SEPSIS DIAGNOSTICS MARKET – BY COUNTRY ANALYSIS
13.1 Europe: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.5 France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.8 France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.1 Overview
13.1.2.5.2 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.1 Overview
13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
14. SEPSIS DIAGNOSTICS MARKET–INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. COMPANY PROFILES
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Axis-Shield Diagnostics Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. Organic Developments in the Sepsis Diagnostics Market
Table 44. Inorganic Developments in the Sepsis Diagnostics Market
Table 45. Glossary of Terms
Table 1. Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. Organic Developments in the Sepsis Diagnostics Market
Table 44. Inorganic Developments in the Sepsis Diagnostics Market
Table 45. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Sepsis Diagnostics Market Segmentation
Figure 2. Europe Sepsis Diagnostics Market, By Country
Figure 3. Europe Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Europe Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028
Figure 10. Europe Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Europe Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Europe Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Europe Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Europe Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Europe Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Europe Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Europe Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Europe Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Europe Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Europe Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Europe Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Europe Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Europe Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Europe Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 27. Europe Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Europe Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 30. Europe Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Europe Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 33. Europe Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Europe Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 37. Europe Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Europe Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Europe: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42. Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Growth Strategies in the Sepsis Diagnostics Market (%)
Figure 1. Europe Sepsis Diagnostics Market Segmentation
Figure 2. Europe Sepsis Diagnostics Market, By Country
Figure 3. Europe Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Europe Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028
Figure 10. Europe Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Europe Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Europe Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Europe Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Europe Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Europe Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Europe Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Europe Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Europe Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Europe Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Europe Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Europe Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Europe Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Europe Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Europe Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 27. Europe Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Europe Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 30. Europe Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Europe Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 33. Europe Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Europe Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 37. Europe Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Europe Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Europe: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42. Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Growth Strategies in the Sepsis Diagnostics Market (%)
